A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.

Clinical trial NCT02734004 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02734004
Sponsor: AstraZeneca
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Breast SCLC Gastric Cancers

Start date: 2016-03-17
Primary completion: 2021-09-17
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.